Replies to post #2176 on Cyclo Therapeutics Inc (CYTH)

[curber]

CTDH, I like the orphan drug angle, this may be a niche they could go after, especially with the 7 year exclusive. Right now the CYCLO is a 50k a year treatment. With 200+ afflicted with NPC in the U.S. this could be a $10.0m in sales company IMHO